Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Beam Therapeutics Inc. | 180,000 | reported | 31 Jan 2026 | tx 149+1,986,644−1,277,680 |
| Verve Therapeutics, Inc. | 15,500 | reported | 09 Jun 2022 | tx 1+15,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Jan 2026 | SALE | Beam Therapeutics Inc. | 2,906 | 29.00 USD | |
| 30 Jan 2026 | SALE | Beam Therapeutics Inc. | 22,094 | 28.27 USD | |
| 30 Jan 2026 | EXERCISE | Beam Therapeutics Inc. | 25,000 | 0.67 USD | |
| 29 Jan 2026 | EXERCISE | Beam Therapeutics Inc. | 19,336 | 0.67 USD | |
| 29 Jan 2026 | EXERCISE | Beam Therapeutics Inc. | 5,664 | 0.67 USD | |
| 29 Jan 2026 | SALE | Beam Therapeutics Inc. | 16,333 | 29.19 USD | |
| 29 Jan 2026 | SALE | Beam Therapeutics Inc. | 8,667 | 29.74 USD | |
| 31 Jan 2026 | GRANT_AWARD | Beam Therapeutics Inc. | 180,000 | 0.00 USD | deriv |
| 30 Jan 2026 | EXERCISE | Beam Therapeutics Inc. | 25,000 | 0.00 USD | deriv |
| 29 Jan 2026 | EXERCISE | Beam Therapeutics Inc. | 19,336 | 0.00 USD | deriv |
| 29 Jan 2026 | EXERCISE | Beam Therapeutics Inc. | 5,664 | 0.00 USD | deriv |
| 01 Oct 2025 | SALE | Beam Therapeutics Inc. | 25,000 | 24.51 USD | |
| 02 Oct 2025 | SALE | Beam Therapeutics Inc. | 25,000 | 24.63 USD | |
| 02 Oct 2025 | EXERCISE | Beam Therapeutics Inc. | 25,000 | 0.67 USD | |
| 01 Oct 2025 | EXERCISE | Beam Therapeutics Inc. | 25,000 | 0.67 USD | |
| 02 Oct 2025 | EXERCISE | Beam Therapeutics Inc. | 25,000 | 0.00 USD | deriv |
| 01 Oct 2025 | EXERCISE | Beam Therapeutics Inc. | 25,000 | 0.00 USD | deriv |
| 01 Apr 2025 | SALE | Beam Therapeutics Inc. | 30,663 | 18.35 USD | |
| 31 Mar 2025 | GRANT_AWARD | Beam Therapeutics Inc. | 77,500 | 0.00 USD | |
| 30 Jan 2025 | SALE | Beam Therapeutics Inc. | 200 | 27.28 USD | |
| 30 Jan 2025 | SALE | Beam Therapeutics Inc. | 29,800 | 26.75 USD | |
| 31 Jan 2025 | GRANT_AWARD | Beam Therapeutics Inc. | 155,000 | 0.00 USD | deriv |
| 30 Sept 2024 | SALE | Beam Therapeutics Inc. | 60,000 | 24.60 USD | |
| 27 Jun 2024 | SALE | Beam Therapeutics Inc. | 60,000 | 24.50 USD | |
| 01 Apr 2024 | SALE | Beam Therapeutics Inc. | 18,102 | 32.13 USD |
1 purchase reported after at least 12 months of silence — most recent on 06 Mar 2023.